Diabetic ketoacidosis in patients with SARS-CoV-2: a systematic review and meta-analysis.
Saad AlhumaidAbbas Al MutairZainab Al AlawiAli A RabaanMohammed A AlomariSadiq A Al SalmanAhmed S Al-AlawiMohammed H Al HassanHesham AlhamadMustafa A Al-KameesFawzi M AlmousaHani N MuftiAli M AlwesabaiKuldeep DhamaJaffar A Al-TawfiqAwad Al-OmariPublished in: Diabetology & metabolic syndrome (2021)
DKA is not uncommon in SARS-CoV-2 patients with diabetes mellitus and results in a mortality rate of 25.9%. Mortality key determinants in DKA patients with SARS-CoV-2 infection are individuals with pre-existing diabetes mellitus type 2, older age [≥ 60 years old], male gender, BMI ≥ 30, blood glucose level > 1000 mg/dl, and anion gap ≥ 30 mEq/l.